ENDRA Life Sciences to Host Fourth Quarter 2019 Financial Results Conference Call and Webcast on Thursday, March 26, 2020 at 4:30 p.m. ET

ANN ARBOR, MI / ACCESSWIRE / March 9, 2020 / ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that its fourth quarter financial results will be released on Thursday, March 26, 2020 after the U.S. financial markets close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide an update on recent corporate developments.

Dial-in Number
U.S./Canada Dial-in Number: 844-602-0380
International Dial-in Number: 862-298-0970

Replay Dial-in Number: 877-481-4010
Replay International Dial-in Number: 919-882-2331
Replay Passcode: 33509

A telephone replay will be available March 26, 2020 through 4:30 p.m. ET on April 9, 2020.

A live audio webcast will be available through the Events and Presentations page of the Investors section of the company’s website at www.endrainc.com. A replay of the webcast will be available on the website for 90 days.

About ENDRA Life Sciences Inc.

ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), a ground-breaking technology being developed to visualize tissue like CT or MRI, but at 1/50thof the cost, at the point of patient care. TAEUS is designed to work in concert with the over one million ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver, as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.www.endrainc.com

Company Contact:

David Wells
Chief Financial Officer
(734) 997-0464
investors@endrainc.com
www.endrainc.com

Media & Investor Relations Contact:

MacDougall
Amanda Houlihan
(781) 235-3060
endra@macbiocom.com

SOURCE: ENDRA Life Sciences Inc.

View source version on accesswire.com:
https://www.accesswire.com/579541/ENDRA-Life-Sciences-to-Host-Fourth-Quarter-2019-Financial-Results-Conference-Call-and-Webcast-on-Thursday-March-26-2020-at-430-pm-ET

Staff

Recent Posts

OSSIO expands portfolio of highly differentiated bio-integrative fixation implants with small compression staples to enhance bunion repair patients’ satisfaction

Revolutionary material science innovation, OSSIOfiber® continues to evolve standard of care in orthopedic surgeryWOBURN, Mass.--(BUSINESS…

2 hours ago

Pavion Acquires Signet

Expanding New England Footprint and Leadership in Critical Communications CHANTILLY, Va., June 19, 2024 /PRNewswire/…

2 hours ago

AvaSure Chief Nursing Executive Advisory Board Collaborates on Inpatient Virtual Care Maturity Model

Industry experts share insights to modernize care delivery models for the virtual nursing market BELMONT,…

2 hours ago

Prochant Revolutionizes Infusion Pharmacy Intake Financial Processes with the Latest Enhancement to Prochant Pulse

CHARLOTTE, N.C., June 19, 2024 /PRNewswire/ -- Prochant, the leader in home-based care revenue cycle…

2 hours ago

Pelvic Rehabilitation Medicine Launches Online Community for Endometriosis and Pelvic Pain Patients

Worthy Warrior is a safe place for patients to listen, learn, and validate. WEST PALM…

2 hours ago

Sensitech to Strengthen Life Sciences Cold Chain Solutions with Acquisition of Berlinger & Co. Monitoring Solutions

BEVERLY, Mass., June 19, 2024  /PRNewswire/ -- Carrier Global Corporation, on behalf of its Sensitech…

2 hours ago